The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

about

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

Item

http://www.wikidata.org/entity/Q58551063

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 16 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@en

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@nl

type

Item

label

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@en

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@nl

prefLabel

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@en

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@nl

P1476

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

@en

P2093

Abed Tarapdar

http://www.w3.org/2001/XMLSchema#string

Galina Mukamolova

http://www.w3.org/2001/XMLSchema#string

James K S Norris

http://www.w3.org/2001/XMLSchema#string

James T Hodgkinson

http://www.w3.org/2001/XMLSchema#string

Oliver Sampson

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines

Vibriobactin antibodies: a vaccine strategy.

Antimicrobial resistance: a global multifaceted phenomenon.

Bacteria in an intense competition for iron: Key component of the Campylobacter jejuni iron uptake system scavenges enterobactin hydrolysis product

Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications.

Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.

Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.

Screening system for xenosiderophores as potential drug delivery agents in mycobacteria

Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli.

P304

2646-2650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3762/BJOC.14.242

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410626

http://www.w3.org/2001/XMLSchema#string

P932

6204836

http://www.w3.org/2001/XMLSchema#string